These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30052304)

  • 1. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
    Schmitto JD; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Sood P; Damme L; Netuka I
    Eur J Heart Fail; 2019 Jan; 21(1):90-97. PubMed ID: 30052304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.
    Krabatsch T; Netuka I; Schmitto JD; Zimpfer D; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Damme L; Pya Y
    J Cardiothorac Surg; 2017 Apr; 12(1):23. PubMed ID: 28376837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.
    Netuka I; Sood P; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Marasco S; Beyersdorf F; Damme L; Schmitto JD
    J Am Coll Cardiol; 2015 Dec; 66(23):2579-2589. PubMed ID: 26670056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes.
    Zimpfer D; Netuka I; Schmitto JD; Pya Y; Garbade J; Morshuis M; Beyersdorf F; Marasco S; Rao V; Damme L; Sood P; Krabatsch T
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):548-54. PubMed ID: 27436871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry.
    Zimpfer D; Gustafsson F; Potapov E; Pya Y; Schmitto J; Berchtold-Herz M; Morshuis M; Shaw SM; Saeed D; Lavee J; Heatley G; Gazzola C; Garbade J
    Eur Heart J; 2020 Oct; 41(39):3801-3809. PubMed ID: 33107561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes of patients supported with HeartMate 3: a single-centre experience.
    Schmitto JD; Mariani S; Li T; Dogan G; Hanke JS; Bara C; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Netuka I; Bauersachs J; Haverich A
    Eur J Cardiothorac Surg; 2021 Jun; 59(6):1155-1163. PubMed ID: 33585913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-life experience with HeartMate III.
    Marasco SF; Farag J; Kure C; Summerhayes R; Bailey M; McGiffin D
    J Card Surg; 2019 Oct; 34(10):1031-1036. PubMed ID: 31376201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
    Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
    Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Years of Experience in the Implantation of Heartmate III.
    Mendes V; Cerca C; Crosset M; Kirsh M
    Rev Port Cir Cardiotorac Vasc; 2017; 24(3-4):120. PubMed ID: 29701352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term single-centre experience with the HeartMate 3 left ventricular assist device for advanced heart failure.
    Nowacka A; Hullin R; Tozzi P; Barras N; Regamey J; Yerly P; Rosner L; Marcucci C; Rusca M; Liaudet L; Kirsch M
    Eur J Cardiothorac Surg; 2020 Sep; 58(3):511-518. PubMed ID: 32236472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).
    Stehlik J; Estep JD; Selzman CH; Rogers JG; Spertus JA; Shah KB; Chuang J; Farrar DJ; Starling RC;
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system.
    Morshuis M; El-Banayosy A; Arusoglu L; Koerfer R; Hetzer R; Wieselthaler G; Pavie A; Nojiri C
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1020-7; discussion 1027-8. PubMed ID: 19233673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
    Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.